EP2317917A2 - Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système - Google Patents

Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système

Info

Publication number
EP2317917A2
EP2317917A2 EP09741188A EP09741188A EP2317917A2 EP 2317917 A2 EP2317917 A2 EP 2317917A2 EP 09741188 A EP09741188 A EP 09741188A EP 09741188 A EP09741188 A EP 09741188A EP 2317917 A2 EP2317917 A2 EP 2317917A2
Authority
EP
European Patent Office
Prior art keywords
electrically conductive
conductive means
secondary device
organism
resonant circuit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09741188A
Other languages
German (de)
English (en)
Inventor
Heribert Stephan
Werner Kraus
Stephanie Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neue Magnetodyn GmbH
Original Assignee
Neue Magnetodyn GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neue Magnetodyn GmbH filed Critical Neue Magnetodyn GmbH
Publication of EP2317917A2 publication Critical patent/EP2317917A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/076—Permanent implantations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4504—Bones

Definitions

  • the invention relates to a system for acquiring measured values in or on an organism.
  • the invention relates to a method for producing a component of such a system.
  • Coronary heart disease is the leading cause of death in the industrialized world. More than 1.5 million interventions to dilate narrowed or occluded vessels are carried out worldwide each year. Such interventions include, for example, percutaneous transluminal coronary angioplasty (PTCA). For some of these interventions, stents are implanted at the same time. However, the success of these measures is often called into question by the high probability of restenosis. In about 30 to 50% of patients undergoing balloon dilatation and in about 22 to 30% of patients with stents, restenosis occurs within six months of intervention, that is, reocclusion of the vessels. In Germany alone, 25,000 patients had to be re-operated in 2000, which resulted in costs of around 500 million euros.
  • PTCA percutaneous transluminal coronary angioplasty
  • infections exist not only in connection with vascular supports or vascular prostheses, but also in other implants, such as osteosynthesis or endoprostheses of joints or other skeletal components.
  • infections are often caused by the formation of biofilms on the implants, which, for example, harbor the difficult-to-fight multi-resistant Staphylococcus aureus (MRSA).
  • MRSA multi-resistant Staphylococcus aureus
  • the present invention is therefore based on the task of early detection of a threatening or incipient change in the area of implants by non-invasive measures and to provide the technical facilities required for this purpose.
  • the invention consists in a system for recording measured values in or on an organism, with at least one attachable to the organism or implantable in the organism secondary device, the impedance of which depends on a state of the environment of the implantable secondary device, an organismextern platzable acting as a primary coil assembly for Generating an alternating electromagnetic field in the region of the secondary device in an implanted state and an evaluation device which can be placed externally in the organism for detecting and evaluating measured values which are dependent on the impedance of the second dependent, wherein the secondary means comprises electrically conductive means, which are applied using thin-film technology.
  • thin-film technology virtually any implants can be equipped with electrical properties in such a way that they interact with an electromagnetic alternating field generated by an organism-external coil arrangement.
  • This interaction can be detected organism-externally in various ways, so that changes in the area of the secondary device, in particular of an implant, can be detected on a non-invasive basis.
  • hyperplasias that is, excessive cell growth
  • stents likewise the beginning of the formation of a biofilm on an implant.
  • the secondary device has an electrical resonant circuit whose impedance and resonance frequency depends on the state of the environment of the secondary device. If the externally generated alternating electromagnetic field meets the resonance frequency, this can be detected and evaluated by the evaluation device. If the environment of the secondary device changes, be it through cell growth, cross-sectional change in the vessel or biofilm formation, this has an effect on the impedance of the resonant circuit, which changes its resonant frequency. Consequently, the organism-external evaluation device can detect a change in the area of the implant and thus indicate an imminent complication.
  • the system according to the invention is developed in a particularly useful manner in that the electrically conductive means comprise first electrically conductive means applied to the implantable secondary device, which form part of a resonant circuit, that an electrically insulating layer is applied to the first electrically conductive means, in that second electrically conductive means, which form a further constituent part of the resonant circuit, are applied to the electrically insulating layer, and that the first electrically conductive means are contacted with the second electrically conductive means, so that the resonant circuit is formed.
  • the electrically conductive means comprise first electrically conductive means applied to the implantable secondary device, which form part of a resonant circuit, that an electrically insulating layer is applied to the first electrically conductive means, in that second electrically conductive means, which form a further constituent part of the resonant circuit, are applied to the electrically insulating layer, and that the first electrically conductive means are contacted with the second electrically conductive means, so that the resonant circuit is
  • the first electrically conductive means have an outer area with windings and an inner area with capacitive properties.
  • the secondary device has a measuring device which detects measured values dependent on the state of the tissue surrounding the secondary device, that the secondary device has a transmitting device which emits signals dependent on the measured values, and an organism-externally placeable receiving device is provided which receives the signals emitted by the transmitting device and supplies them to the evaluation device. While the embodiments of the invention described so far are based on the variation of the resonant frequency of a resonant circuit, provision may also be made for equipping the secondary device with a measuring device which detects various properties in the region of the device by means of sensors.
  • An example of such a sensor is the ion-sensitive MOS-FET (ISFET).
  • ISFET ion-sensitive MOS-FET
  • the usual polysilicon gate is replaced by a sensor-specific metallization.
  • the use of different materials allows the realization of sensors that are sensitive to gases or to ion concentrations in liquid solutions. These devices serve as basic structures for biosensors. Signals which correspond to the values detected by the measuring device can then be emitted by a transmitting device and evaluated externally in the organism. In the present case, the application of the organism-external alternating field thus serves primarily to transport the energy required for the operation of the measuring device into the organism.
  • the transmitting device has at least one RFID transponder.
  • An RFID transponder is a device which can only "send out” its interaction with an evaluation device or a reading device realized by the receiving device.
  • the RFID transponder receives an electromagnetic high-frequency field which is generated by the evaluation device or the reading device, in order to then change this as a function of information stored in the RFID transponder. This change is made by the evaluation device or the reading device. advises. Because of this compared to conventional active transmitters limited functionality of an RFID transponder, this is inexpensive and space-saving.
  • the information transmission from the RFID transponder to the evaluation device can take place on the basis that a readable information content of the RFID transponder is variable as a function of measured values which are supplied by the measuring device.
  • different voltages are applied to the memory of the RFID transponder by the measuring device, these voltages reflecting the characteristics detected by the measuring device.
  • Different voltages can now cause the memory contents of the RFID transponder to be changed, so that ultimately the identifier transmitted by the RFID transponder to the evaluation unit is also changed.
  • a plurality of RFID transponders are provided which can be activated or deactivated in dependence on measured values which are supplied by the measuring device. In this case, unwritable transponders are sufficient.
  • One or more threshold value circuits, in which the measuring device and the RFID transponder are integrated, ensure that different RFID transponders are active or inactive depending on the voltage supplied by the measuring device. In this way, the evaluation device can thus receive different identifiers depending on the voltage delivered by the measuring device, ie on this basis also ensure that the corresponding information is transmitted to the evaluation device arranged outside of the organism.
  • the invention further consists in a method for producing a Sekundärein- device in which by means of a primary device, an electrical voltage is inducible, with the steps of providing an implant, applying first electrically conductive means to the implant, which are to form part of a resonant circuit, applying an electrically insulating layer on the electrically conductive means, applying second electrically conductive means to the electrically insulating layer, which are to form a further part of the resonant circuit, and Kon- Clock the first electrically conductive means with the second electrically conductive Mit ⁇ tel, so that the resonant circuit is formed.
  • a structure is provided by a few procedural ⁇ rensuzee which is required for the resonance frequency analysis functionality.
  • the first electrically conductive means have an outer region with turns and an inner region with capacitive properties.
  • the manufacturing method is further developed in a particularly useful and simple manner by applying the first electrically conductive means and / or the electrically insulating layer and / or the second electrically conductive means using thin-film technology.
  • the present invention two different concepts for measuring a property around the implanted secondary device are thus used with the present invention.
  • the first measurement principle a change in the impedance or the resonance frequency of an implanted resonant circuit is evaluated in a simple manner. This method requires no active components in the organism, so that the problem of biocompatibility is reduced.
  • the external field preferably operates in a range between one kHz to one GHz, preferably in the range between 4 kHz and 120 kHz.
  • the second measuring principle is based on the coupling of electromagnetic energy in the secondary device, in which case the actual detection of the environmental condition is supported by active components.
  • the frequency can for example be chosen so that as much energy as possible is transmitted in the shortest possible time, or the frequency range used is determined on the basis of completely different criteria.
  • coil arrangements which are referred to as transducer coils, are integrated into these implants, and their poles are electrically connected to implant sections which act as electrodes.
  • An example of osteosynthesis A seeinrichtug making use of the described technique is disclosed in DE 10 2006 018 191 A1.
  • the femoral head cap implants described in 10 2004 024 473 A1 are examples of the use of the art in joint endoprosthesis. If, therefore, the organism-external coils are tuned to the frequency range of 1 to 30 Hz, preferably 10 to 20 Hz, required in the Kraus and Lechner technology, this technique can be used on the one hand and the power required to operate the measuring device on the other hand Energy are transferred to the system according to the invention.
  • Another potential application is the non-invasive monitoring of bone growth in fractures treated with osteosynthesis material (e.g., osteosynthesis plate, intramedullary nail).
  • osteosynthesis material e.g., osteosynthesis plate, intramedullary nail.
  • the change in impedance which is also detected with electrodes deposited on an insulating interlayer, may shed light on the progress of the bony consolidation of the fracture. Repeated X-raying can thus be avoided.
  • the application of the insulating intermediate layer and the electrodes can likewise be effected by means of thin-film technology.
  • implants are equipped with magnetically conductive properties, so that a concentration of the magnetic field takes place in the region of the implantable device by external magnetic fields. If the implantable device is located in the region of flowing body fluids, for example in a blood vessel, a concentration of the same in the region of the implantable device can be achieved by administering paramagnetic nanoparticles with active substances or cells coupled thereto.
  • Both the first embodiment of the present invention with a bare electrical resonant circuit and the second embodiment with active components can be combined with the drug-targeting technology, namely by the organism-externally generated electromagnetic field on the one hand in the region of the implant for the purpose of the concentration of active ingredients or cells, on the other hand, either resonant frequency monitored or provides energy for active components in the region of the implant.
  • Figure 1 shows a first embodiment of a system according to the invention
  • Figure 2 shows a second embodiment of a system according to the invention
  • FIG 3 shows a secondary device for use in a system according to the invention.
  • FIG. 1 shows a first embodiment of a system according to the invention.
  • a secondary device 12 is implanted in an organism 10, that is in particular a living human body.
  • a coil assembly 14, 16 is provided, which acts as a primary means and is adapted to generate in the region of the secondary device 12, an electromagnetic field.
  • the coil arrangement may, for example, be realized by Helmholtz coils 14, 16, as shown, but also in other ways. It is essential that an electromagnetic field is present in the area of the secondary device 12.
  • the organism-external coils 14, 16 are powered by a functional current generator 18 with energy.
  • the secondary device 12 is now equipped with electrically conductive means 22, which form an electrical resonant circuit.
  • the impedance and the resonant frequency of this electrical resonant circuit depends on the state of its environment, in particular on the tissue state, the presence or absence of biofilms or any other parameters that reflect the conditions in the organism 10. If, for example, the frequency of the functional current generator 18 is set such that it corresponds to the resonant frequency of the resonant circuit formed by the electrically conductive means 22, then this resonant state can be monitored by the evaluating device 20. Now shifts the resonance frequency of the organism-internal resonant circuit, so are changes in the field of Secondary device 12, this is also detected by the evaluation device 20.
  • the secondary device 12 is a stent
  • this may indicate excessive cell growth.
  • the formation of biofilms on implants forming the secondary device 12 can be recognized early. It is not absolutely necessary to operate the external alternating field with the resonant frequency of the resonant circuit; Other spectral components are also influenced by the changing conditions in the area of the secondary device.
  • FIG. 2 shows a second embodiment of a system according to the invention.
  • the state detection of the secondary device 12 here is not necessarily based on the monitoring of a resonance state. Rather, the secondary device 12 is equipped with a measuring device 34 and a transmitting device 36.
  • the measuring device 34 and the transmitter 36 are energized via the electrically conductive means 22 which receive the electrically conductive means 22 from the electromagnetic field generated by the organism-external coil arrangement 14, 16.
  • the measuring device 34 can comprise any desired sensors in order to detect state parameters in the region of the secondary device 12. For example, it is possible in turn to detect impedances or also other parameters, for example the pH value, in the latter case the measuring device 34 usefully having an ion-sensitive field-effect transistor.
  • the signals emitted by the transmitting device 36 are received by a receiving device 38, which forwards them to an evaluation device 20.
  • FIGS. 1 and 2 The devices described in connection with the previously described embodiments according to FIGS. 1 and 2, in particular the electrical means 22, the measuring device 34, the transmitting device 36, the receiving device 38, the evaluation device 20 and the functional current generator 18, can be implemented individually as well as in integrated form become.
  • the electrical means 22, the measuring device 34 and the transmitting device 36 are realized partially or completely integrated.
  • the receiving device 38 and / or the evaluation device 20 can be completely or partially integrated with the functional current generator 18.
  • Figure 3 shows a secondary device for use in a system according to the invention.
  • the secondary device 12 carries electrically conductive means 22, which form an electrical resonant circuit 24.
  • An outer region 30 of the electrically conductive means 22 has turns, that is, inductive properties, while an inner region 32 has capacitive properties.
  • the conductor structure realized with solid lines is first applied to the electrically insulating secondary device 12.
  • This conductor structure is referred to as first electrically conductive means 26. If the secondary device 12 is not insulated in any case, an insulating layer is applied to the secondary device 12 before the application of the first electrically conductive means 26. After the application of the first electrically conductive means 26, an insulating layer is applied to the first electrically conductive means 26. Subsequently, second electrically conductive means 28 are applied to the insulating layer not visible here.

Abstract

Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, à l'aide d'au moins un dispositif secondaire (12) pouvant être appliqué sur l'organisme ou implanté dans ce dernier et dont l'impédance dépend d'un état de l'environnement dudit dispositif secondaire implantable, un ensemble de bobines (14, 16) pouvant être placé à l'extérieur de l'organisme et servant de dispositif primaire, destiné à produire un champ magnétique alternatif dans la zone du dispositif secondaire implanté, et un dispositif d'analyse (20) pouvant être placé à l'extérieur de l'organisme, pour recueillir et analyser les valeurs de mesure qui dépendent de l'impédance du dispositif secondaire, ledit dispositif secondaire comportant des moyens électro-conducteurs appliqués à l'aide de la technologie des couches minces.
EP09741188A 2008-07-18 2009-07-17 Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système Withdrawn EP2317917A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008033805A DE102008033805A1 (de) 2008-07-18 2008-07-18 System zum Erfassen von Messwerten in oder an einem Organismus und Verfahren zum Herstellen einer Komponente dieses Systems
PCT/DE2009/001000 WO2010006592A2 (fr) 2008-07-18 2009-07-17 Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système

Publications (1)

Publication Number Publication Date
EP2317917A2 true EP2317917A2 (fr) 2011-05-11

Family

ID=41401838

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09741188A Withdrawn EP2317917A2 (fr) 2008-07-18 2009-07-17 Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système

Country Status (6)

Country Link
US (1) US20110152713A1 (fr)
EP (1) EP2317917A2 (fr)
CN (1) CN102143708A (fr)
AU (1) AU2009270625A1 (fr)
DE (1) DE102008033805A1 (fr)
WO (1) WO2010006592A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2433562B1 (fr) * 2010-09-28 2014-07-09 BIOTRONIK SE & Co. KG Système de capteur médical pour contrôler au moins une caractéristique dans au moins un corps animal et/ou humain

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6092530A (en) * 1999-03-24 2000-07-25 The B.F. Goodrich Company Remotely interrogated implant device with sensor for detecting accretion of biological matter
US6206835B1 (en) * 1999-03-24 2001-03-27 The B. F. Goodrich Company Remotely interrogated diagnostic implant device with electrically passive sensor
CA2539261C (fr) * 2003-09-16 2011-05-17 Cardiomems, Inc. Detecteur implantable sans fil
WO2005027785A2 (fr) * 2003-09-18 2005-03-31 Advanced Bio Prosthetic Surfaces, Ltd. Dispositif medical integrant des fonctionnalites de systemes micro-electromecaniques, et procedes de fabrication correspondants
DE102004024473B4 (de) * 2004-05-14 2010-06-17 Neue Magnetodyn Gmbh Hüftkopfkappenimplantat mit Vorrichtung zur elektrischen Gewebestimulation
US7993269B2 (en) * 2006-02-17 2011-08-09 Medtronic, Inc. Sensor and method for spinal monitoring
DE102006018191B4 (de) * 2006-04-19 2008-08-07 Neue Magnetodyn Gmbh Elektrisches Marknagelsystem
EP2786701B1 (fr) * 2006-08-29 2015-12-23 California Institute of Technology Capteur de pression sans fil implantable microfabriqué destiné à être utilisé dans des applications biomédicales, et procédés de mesure de pression et d'implantation de capteur
US20080077016A1 (en) * 2006-09-22 2008-03-27 Integrated Sensing Systems, Inc. Monitoring system having implantable inductive sensor
WO2009010303A2 (fr) * 2007-07-18 2009-01-22 Neue Magnetodyn Gmbh Système d'administration de substances actives à un organisme, dispositifs d'utilisation d'un tel système et procédé de fabrication de tels dispositifs
GB0808266D0 (en) * 2008-05-07 2008-06-11 Univ Strathclyde System for characterising or monitoring implanted devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010006592A2 *

Also Published As

Publication number Publication date
WO2010006592A3 (fr) 2010-03-11
WO2010006592A2 (fr) 2010-01-21
CN102143708A (zh) 2011-08-03
AU2009270625A1 (en) 2010-01-21
DE102008033805A1 (de) 2010-01-21
US20110152713A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
DE60018262T2 (de) Verfahren zur Erzeugung eines Impedanzspektrums, das für eine Probe einer Körpersubstanz charakteristisch ist
EP1990027B1 (fr) Implant médical, en particulier stent destiné à l'utilisation dans des lumières corporelles
DE112008003193T5 (de) Anordnung verbundener Mikrotransponder für Implantation
DE112008003184T5 (de) Impulsstimulationssysteme und -verfahren für implantierbare Transponder
DE112008003192T5 (de) Übertragungsspulenarchitektur
DE102004059082A1 (de) Vorrichtung zum Bestimmen der Thorax-Impedanz
WO2009043512A1 (fr) Marqueur de tissu
DE19746735A1 (de) NMR-Blidgebungsverfahren zur Darstellung, Positionsbestimmung oder funktionellen Kontrolle einer in ein Untersuchungsobjekt eingeführten Vorrichtung und Vorrichtung zur Verwendung in einem derartigen Verfahren
DE202005009809U1 (de) Datenübertragungssystem in Verbindung mit einem Implantat
EP1926445A1 (fr) Auxiliaire d'osteosynthese
EP2213228A2 (fr) Appareil de mesure de dégradation et d'intégrité pour implants métalliques résorbables
EP2579769A1 (fr) Capteur d'analyte pourvu d'une antenne à fente
DE102005039455A1 (de) Träger und Implantat zum Einführen in Hohlkörper
EP2668472B1 (fr) Dispositif cylindrique, système de mesure de la vitesse de l'onde de pouls et procédé de mesure de la vitesse de l'onde de pouls
DE102008005180A1 (de) Vorrichtung mit einem Prothesenteil und einem Sensor zum in-vivo-Überprüfen der Lockerung des Prothesenteils
DE102006014883A1 (de) Verfahren zum Orten eines invasiven Instruments und invasives Instrument
EP2317917A2 (fr) Système d'acquisition de valeurs de mesure dans un organisme ou sur ce dernier, et procédé de fabrication d'un composant de ce système
WO2009010303A2 (fr) Système d'administration de substances actives à un organisme, dispositifs d'utilisation d'un tel système et procédé de fabrication de tels dispositifs
DE102006016043A1 (de) Sicherheitssystem sowie Verfahren zur Feststellung einer möglichen Gefährdung einer Person durch ein Gerät
DE102014109683B4 (de) Vorrichtung zur Detektion einer Lockerung und/oder Abnutzung einer Endoprothese
DE102020121954A1 (de) Anordnung zur Ermittlung des Zustandes von Implantaten umgebenden Geweben, des Einwachsverhaltens sowie des Lockerungszustandes von Implantaten
DE102011013308B4 (de) Hochfrequenz-resonante Stents für das nicht-invasive Restenose-Monitoring
DE102012218673A1 (de) Vorrichtung und Verfahren zur Messung des Verankerungszustandes von Implantaten
DE102019132549B4 (de) Immunmodulatoranordnung zur Behandlung von Krebserkrankungen und Verfahren zur topischen Einkopplung von in Betrag und Richtung wechselnder Energie
DE202015009423U1 (de) In vivo implantierbares Diagnosegerät

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110218

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140227

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150203